ArticleFrontiers in neurology2023

APRIL: A double-blind, placebo-controlled, randomized, Phase Ib/IIa clinical study of ApTOLL for the treatment of acute ischemic stroke.

Macarena Hernández-Jiménez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.